Caitta Inc., doing business as Caitta Inc., has been awarded a $310,539.45 firm-fixed-price purchase order contract by the Department of Health and Human Services' Food and Drug Administration to supply one Morphologically Directed Raman Spectroscopy System by Malvern Analytical. The place of performance is in Silver Spring, Maryland, with a period of performance from April 23, 2020 to May 30, 2020. This total small business set-aside contract fulfills the FDA's solicitation seeking a Raman spectroscopy system for pharmaceutical analysis, including ingredient mapping, particle analysis, and regulatory research. The system must meet specified characteristics for morphological analysis, Raman spectroscopy, software integration, and sample analysis of various drug formulations.